An underground economy for unapproved weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.
Experimental Treatment Gaining Traction Online
Retatrutide, which is still in clinical trials, is being advertised by online personalities for its supposed fat-burning effects. Followers are encouraged to message these accounts directly for source information, while also receiving discount codes.
Thriving Trade on Social Networks
Additionally, a flourishing market exists on Telegram, where groups with numerous of participants share “before and after” images, injection guides and claims of rapid UK delivery. Sellers promote the substance there before redirecting buyers to WhatsApp for purchases.
Learning About Retatrutide
This medication is an experimental injection created by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.
Healthcare Professionals Voice Concerns
However, doctors and chemists have warned that the distribution of what is still an unlicensed drug in the UK is a cause for concern and could lead to users administering products of unknown origin.
Some experts stated the demand for retatrutide could be linked to the increasing cost of licensed weight loss products such as Mounjaro.
Regulatory Status and Enforcement
Marketing the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unlicensed drug that cannot be marketed or supplied for human use under the British medical regulations.
Some influencers try to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but promotion and distribution can still breach medicines, advertising, and consumer laws, potentially leading to penalties, prosecution or imprisonment.
Service Response and Content Removal
Based on the social media company, the service has removed problematic material and banned related keywords and search suggestions. The organization stated it was committed to keeping the service secure and allocating resources in enhancing enforcement strategies.
Online Trading Operations
Investigations also found communities with up to nine thousand members marketing retatrutide using the platform's built-in search feature, which functions like a online catalog. Entering “retatrutide” instantly displays channels with thousands of members, filled with photos of weight loss, positive reviews and detailed instructions for mixing or injecting at home.
After minutes of entering one community, a seller posted contact information, where most purchases occur. The seller sent an guidebook and guaranteed delivery within two days. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one inquired about body mass, medical conditions or past usage.
Product Information and Pricing
Within these groups, posts show black plastic packages with Royal Mail labels, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, mixed at home with purified liquid, or pre-filled injectors usually sold at £160 for 20 milligrams. When questioned how much time a pen should last, vendors give contradictory answers varying between a several days to “depends on your body”.
Platform Moderation and Security Measures
A spokesperson for the messaging service stated it regularly moderated dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Medical Expert Warnings
“Individuals are injecting materials they can’t verify. Although the research behind this drug is valid, these digital versions may not contain what they claim,” stated a pharmacy expert, the head of pharmacy at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the increase in demand to recent price rises for authorized weight-loss medications such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But fake injections are highly dangerous. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she explained.
Her staff has previously seen patients harmed by self-injection from unverified sources. “We recognize the frustration, but buying from Telegram or communication platforms is taking chances with your health,” said the doctor. “These substances could be impure or incorrectly dosed.”
Manufacturer Position
A spokesperson from the pharmaceutical company stated the substance was in third stage clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a Lilly investigational product not yet authorized … may expose users to potentially significant medical dangers”.
